Another recently completed phase 3 clinical trial called REDEFINE 2 , which included 1,207 adults with type 2 diabetes and overweight or obesity, found that after 68 weeks, CagriSema led to weight loss of almost 16% experts say the highest yet in the type 2 population, compared to other weight management drugs like tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) and semaglutide
Reports describe clearer cognition and steadier mood regulation, showing its reach goes well beyond injury recovery
Fast, secure USPS shipping, free on orders over $200
Heres why its getting so much attention in longevity and performance optimization spaces: It Works Across Multiple Systems Unlike peptides that target only one function, BPC-157 benefits the gut, brain, joints, muscles, and nervous system all at once, making it a true multi-purpose biohack